First Demonstrated Replication of a Randomized Controlled Trial on Electronic Health Record Data Using the Clinical Intelligence Platform (CLINT)

Did you know around 80% of non-COVID-19 clinical trials have been suspended, stopped, or delayed? The long-term impact on clinical trials is amongst the many threats this virus has presented. HealthPals has identified an unrealized solution in external control arms (ECAs), which can both accelerate time-to-market and lower R&D and RCT costs.

To demonstrate the ability of CLINT to leverage ECAs, HealthPals, in collaboration with Veradigm, successfully replicated the Rocket-AF study in real-world EHR data. Read more for details on the replication results, and how ECAs can change the future of clinical trials

To download the white paper, please fill out the form with your information